Bionomics Ltd (External organisation)

  • Andrew John Harvey (Inventor)
  • Flynn, B. L. (Inventor)
  • Jorgen Alvar Mould (Inventor)
  • Dharam Paul (Inventor)
  • Gurmit Singh Gill (Inventor)
  • Justin Anthony Ripper (Inventor)
  • Rachel Christine Cooke (Inventor)
  • Julia Stephanie Crossman (Inventor)
  • Jonathan Bayldon Baell (Inventor)
  • Nathan Wayne Kuchel (Inventor)
  • Rajinder Singh (Member)

Activity: Industry, Government and Philanthropy Engagement and Partnerships › Patents › Patent

Description

Novel potassium channel blockers and uses thereof

Abstract: The present invention relates to compounds useful in the modulation of potassium channel activity in cells, in particular the activity of Kv1.3 channels found in T cells. The invention also relates to the use of these compounds in the treatment or prevention of autoimmune and inflammatory diseases, including multiple sclerosis, pharmaceutical compositions containing these compounds and methods for their preparation.

WO2009149508A1 - WIPO (PCT)
Application PCT/AU2009/000739 events
2008-06-13 Priority to US6149708P
2008-06-13 Priority to US61/061,497
2009-06-12 Application filed by Bionomics Limited
2009-12-17 Publication of WO2009149508A1
Related patent documents EP2303850 US20110166130 CN102112453 AU2009257189 JP2011522843 CA2727780 NZ589989
Period2009
Held atBionomics Ltd, Australia, South Australia
Degree of RecognitionInternational

Documents & Links